Lymphographie Differential Diagnosis in Malignant Lymphomas

1974 ◽  
pp. 77-88
Author(s):  
K. H. Strickstrock ◽  
P. E. Peters ◽  
H. Weissleder
Keyword(s):  
Differential Diagnosis ◽  
Malignant Lymphomas

Classification and Differential Diagnosis of Malignant Lymphomas, Abstract 126–130, Symposium

2003 ◽  
Vol 199 (4) ◽  
pp. 212
Author(s):  
I. Anagnostopoulos ◽  
A.C. Feller ◽  
M.-L. Hansmann ◽  
V. Diehl ◽  
E.C. Obermann
Keyword(s):  
Differential Diagnosis ◽  
Malignant Lymphomas

Scintillation Scanning of the Spleen in Diseases of the Lymphoreticuloendothelial System

1966 ◽  
Vol 52 (5) ◽  
pp. 357-374
Author(s):  
Giovanni Dragoni ◽  
Faustino Boioli ◽  
Luigi Roncoroni
Keyword(s):  
Differential Diagnosis ◽  
Red Cells ◽  
Spleen Size ◽  
Malignant Lymphomas ◽  
Neoplastic Diseases ◽  
Abdominal Masses ◽  
Size And Morphology

Considerations on the value of scintillation scanning of the spleen, using Cr51 and BMHP-Hg197 labelled red cells, in neoplastic diseases and particularly in malignant lymphomas are reported. The examination was performed in 45 patients and was found useful for the demonstration of changes in spleen size and morphology and for differential diagnosis with abdominal masses. Splenomegalies were studied also through the index of splenic surface. It was also possible the demonstration of « cold areas », corresponding to intrasplenic alterations, as neoplastic infiltration.

Studies on the Use of Membrane Markers for the Differential Diagnosis of Malignant Lymphomas

Oncology ◽  
1979 ◽  
Vol 36 (3) ◽  
pp. 139-143 ◽  
Author(s):  
J. Holowiecki ◽  
D. Lutz ◽  
G. Baumgartner ◽  
H. Hanak ◽  
W. Knapp
Keyword(s):  
Differential Diagnosis ◽  
Malignant Lymphomas ◽  
Membrane Markers

scholarly journals The Development of Hodgkin’s Disease and Lymphoma during Anticonvulsant Therapy

Blood ◽  
1966 ◽  
Vol 28 (3) ◽  
pp. 416-427 ◽  
Author(s):  
GEORGE A. HYMAN ◽  
SHELDON C. SOMMERS
Keyword(s):  
Adverse Effect ◽  
Differential Diagnosis ◽  
Drug Therapy ◽  
Hodgkin's Disease ◽  
Standard Therapy ◽  
Hodgkin’S Disease ◽  
Anticonvulsant Drug ◽  
Atypical Hyperplasia ◽  
Anticonvulsant Drugs ◽  
Malignant Lymphomas

Abstract 1. Six patients in whom Hodgkin’s disease or lymphosarcoma developed during the use of anticonvulsant agents (Dilantin, phenobarbital, Mysoline, Celontin) are reported. 2. The differential diagnosis from pseudolymphoma, the course of these malignant lymphomas, and their therapeutic management are discussed. 3. Based upon information presently available, it could not be determined whether the atypical hyperplasia sometimes observed during anticonvulsant drug therapy is precancerous, or whether these agents may be carcinogenic in certain sensitive individuals. 4. Patients with a seizure disorder who develop lymphoma require standard therapy for both conditions. The anticonvulsant drugs had no evident adverse effect on the course of the lymphoma, although substitution of another agent seems warranted, if possible, for the offending drug.

Tumor Diagnosis

1982 ◽  
Vol 40 ◽  
pp. 262-265
Author(s):  
Bruce Mackay
Keyword(s):  
Electron Microscopy ◽  
Transmission Electron Microscopy ◽  
Differential Diagnosis ◽  
Light Microscopy ◽  
Clinical Examination ◽  
Ultrastructural Study ◽  
Diagnostic Procedures ◽  
Specific Diagnosis ◽  
Transmission Electron ◽  
Microscopic Diagnosis

The broadest application of transmission electron microscopy (EM) in diagnostic medicine is the identification of tumors that cannot be classified by routine light microscopy. EM is useful in the evaluation of approximately 10% of human neoplasms, but the extent of its contribution varies considerably. It may provide a specific diagnosis that can not be reached by other means, but in contrast, the information obtained from ultrastructural study of some 10% of tumors does not significantly add to that available from light microscopy. Most cases fall somewhere between these two extremes: EM may correct a light microscopic diagnosis, or serve to narrow a differential diagnosis by excluding some of the possibilities considered by light microscopy. It is particularly important to correlate the EM findings with data from light microscopy, clinical examination, and other diagnostic procedures.

The Preschool Stuttering Screen for Health Care Professionals

2011 ◽  
Vol 21 (2) ◽  
pp. 59-62
Author(s):  
Joseph Donaher ◽  
Christina Deery ◽  
Sarah Vogel
Keyword(s):  
Risk Factors ◽  
Health Care ◽  
Differential Diagnosis ◽  
Preschool Children ◽  
Health Care Professionals ◽  
Healthcare Professionals ◽  
Evidence Based ◽  
Developmental Profile

Healthcare professionals require a thorough understanding of stuttering since they frequently play an important role in the identification and differential diagnosis of stuttering for preschool children. This paper introduces The Preschool Stuttering Screen for Healthcare Professionals (PSSHP) which highlights risk factors identified in the literature as being associated with persistent stuttering. By integrating the results of the checklist with a child’s developmental profile, healthcare professionals can make better-informed, evidence-based decisions for their patients.

Sign in / Sign up

Export Citation Format

Share Document